Adelman Robert J Insider Trades

Insider Trading History

Track insider trading activity for Adelman Robert J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Metacrine
Metacrine MTCR
10% owner
Holding Value $1.78M 3,059,123 shares
Last Trade
Sep 18, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$28.6M 2,829,123 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $134k 230,000 shares
Last Trade
Sep 18, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.32M 230,000 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 18, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$28.6M 2,829,123 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
No data
No data
$0.58
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $7.38M 4,418,325 shares
Last Trade
Jul 21, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$219M 7,120,144 shares
$30.77
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $8.8M 5,268,325 shares
Last Trade
Jul 21, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.2M 853,000 shares
$30.77
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 21, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$88.9M 2,888,999 shares
$30.77
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 16, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 16, 2020 Sale
No data
No data
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 16, 2020 Sale
No data
No data
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 16, 2020 Sale
No data
No data
$1.67
Alx Oncology Holdings
Alx Oncology Holdings ALXO
Holding Value $0 0 shares
Last Trade
Jul 16, 2020 Sale
No data
No data
$1.67
Aryx Therapeutics
Aryx Therapeutics ARYX
10% owner
Holding Value $1.67k 3,340,139 shares
Last Trade
Nov 14, 2008 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Aryx Therapeutics
Aryx Therapeutics ARYX
10% owner
Holding Value $1.06k 2,125,493 shares
Last Trade
Nov 13, 2007 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$0.00
Aryx Therapeutics
Aryx Therapeutics ARYX
10% owner
Holding Value $150 300,000 shares
Last Trade
Nov 13, 2007 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Aryx Therapeutics
Aryx Therapeutics ARYX
10% owner
Holding Value $0 0 shares
Last Trade
Nov 13, 2007 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$0.00
Aryx Therapeutics
Aryx Therapeutics ARYX
Director
Holding Value $8.33 16,666 shares
Last Trade
Nov 07, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Aryx Therapeutics
Aryx Therapeutics ARYX
10% owner
Holding Value $0 0 shares
Last Trade
Nov 07, 2007 Sale
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up